MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences ROA Ratio 2011-2026 | ANIX
Annual ROA Ratio Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -67.95 | -58.14 | -38.44 | -44.7 | -35.73 | -106.76 | -185.06 | -217.04 | -56.84 | -89.13 | -14.77 | -106.08 | -185.31 | -75.13 | -85.34 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -14.77 | -217.04 | -91.1 |
Quarterly ROA Ratio Anixa Biosciences
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -58.86 | -29.23 | -43.53 | -45.04 | -41.5 | -40.02 | -49.47 | -44.61 | -40.01 | -24.33 | -57.6 | -56.59 | -59.1 | -67.63 | -59.02 | -62.28 | -58.09 | -70.4 | -128.19 | -143.6 | -164.91 | -214.24 | -283.68 | -290.58 | -303.57 | -251.35 | -236.72 | -287.65 | -268.11 | -328.87 | -228.18 | -163.61 | -140.41 | -73.54 | -107.48 | -106.73 | -131.15 | -84.45 | -14.86 | -12.41 | -13.77 | -77.05 | -147.38 | -125.68 | -137.6 | -130.46 | -190.7 | -242.71 | -252.35 | -235.53 | -136.89 | -100.54 | -70.51 | -91.76 | -91.18 | -100.58 | -67.68 | -32.29 | -20.51 | -14.89 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -12.41 | -328.87 | -119.19 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M |  USA |
 |
Bioventus
BVS
|
3.33 | $ 9.0 | 1.47 % | $ 600 M | USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 13.99 | 2.49 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
3.43 | $ 26.24 | 1.59 % | $ 729 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 154.17 | 1.45 % | $ 7.64 B | USA |
 |
DexCom
DXCM
|
13.19 | $ 68.54 | 3.32 % | $ 26.7 B | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 17.77 | 2.6 % | $ 947 M | USA |
 |
Guardant Health
GH
|
-20.67 | $ 88.16 | 1.12 % | $ 11.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | $ 103.95 | 0.1 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 15.57 | 4.15 % | $ 471 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 17.22 | -0.4 % | $ 2.23 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 101.08 | 3.55 % | $ 8.34 B |  Irlanda |
 |
IQVIA Holdings
IQV
|
4.54 | $ 169.85 | 3.01 % | $ 29.2 B | USA |
 |
Danaher Corporation
DHR
|
4.33 | $ 195.65 | 2.23 % | $ 139 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 121.72 | 2.04 % | $ 19.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 198.39 | -0.28 % | $ 22 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
11.3 | $ 113.9 | 1.85 % | $ 34.6 B | USA |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.12 | 0.91 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 9.28 | 10.24 % | $ 263 M | Israel |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.39 | 1.76 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.45 | 3.73 % | $ 2.05 B | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 78.83 | 0.41 % | $ 5.32 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | Israel |
 |
Pacific Biosciences of California
PACB
|
-69.68 | $ 1.41 | 3.68 % | $ 423 M | USA |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 458.61 | 1.1 % | $ 13.2 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 220.43 | 1.77 % | $ 25.2 B |  Schweiz |
 |
Celcuity
CELC
|
-45.6 | $ 115.07 | 0.15 % | $ 4.54 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 18.31 | 5.23 % | $ 410 M | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-39.28 | $ 201.15 | 1.76 % | $ 19.8 B | USA |
 |
OPKO Health
OPK
|
0.64 | $ 1.2 | 0.84 % | $ 833 M | USA |